Gu He
Impact in
- Organic Chemistry top 1%
- Asymmetric Synthesis and Catalysis
- Catalytic C–H Functionalization Methods
- Synthetic Organic Chemistry Methods
- Dermatology top 1%
Papers in
-
- RNA Interference and Gene Delivery 17
- Chemical Synthesis and Analysis 16
- Protein Degradation and Inhibitors 14
- Ubiquitin and proteasome pathways 11
-
- Asymmetric Synthesis and Catalysis 14
- Co-authors
- Bo Han (37 shared papers)Cheng Peng (34 shared papers)Wei Huang (37 shared papers)Xian Jiang (26 shared papers)Xiang Wen (16 shared papers)Lian Wang (17 shared papers)Dan Hao (8 shared papers)Liang Ouyang (26 shared papers)
- Journals
- European Journal of Medicinal Chemistry (10 papers)Journal of Medicinal Chemistry (9 papers)International Journal of Molecular Sciences (5 papers)Organic Letters (5 papers)Frontiers in Immunology (5 papers)
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Gu He
242 papers receiving 7.2k citations
Gu He's Hit Papers
Peers
Comparison fields: 5 of 160
- Organic Chemistry 1.7k
- Dermatology 437
- Molecular Biology 3.0k
- Biomaterials 580
- Pharmaceutical Science 250
Countries citing papers authored by Gu He
This map shows the geographic impact of Gu He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gu He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gu He more than expected).
Fields of papers citing papers by Gu He
This network shows the impact of papers produced by Gu He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gu He. The network helps show where Gu He may publish in the future.
Co-authors
The 25 scholars most cited alongside Gu He, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 250 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Asymmetric organocatalysis: an enabling technology for medicinal chemistry Hit paper breakdown → | 2021 | 319 |
| 2 | Recent advances in targeting the “undruggable” proteins: from drug discovery to clinical trials Hit paper breakdown → | 2023 | 223 |
| 3 | 2019 | 218 | |
| 4 | 2009 | 196 | |
| 5 | 2017 | 174 | |
| 6 | 2019 | 167 | |
| 7 | 2016 | 154 | |
| 8 | 2022 | 130 | |
| 9 | 2017 | 127 | |
| 10 | 2015 | 114 | |
| 11 | 2014 | 93 | |
| 12 | 2023 | 89 | |
| 13 | 2017 | 84 | |
| 14 | 2017 | 84 | |
| 15 | 2010 | 83 | |
| 16 | 2015 | 81 | |
| 17 | 2019 | 78 | |
| 18 | 2012 | 71 | |
| 19 | 2020 | 71 | |
| 20 | 2014 | 68 |
About Gu He
Gu He is a scholar working on Molecular Biology, Organic Chemistry, Cancer Research, Oncology and Immunology, having authored 250 papers that have together received 7.3k indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (17 papers), Chemical Synthesis and Analysis (16 papers), Autophagy in Disease and Therapy (15 papers), Asymmetric Synthesis and Catalysis (14 papers), Protein Degradation and Inhibitors (14 papers), Nanoparticle-Based Drug Delivery (14 papers), Computational Drug Discovery Methods (13 papers) and Ubiquitin and proteasome pathways (11 papers). The work is most often cited by research in Organic Chemistry (1.7k citations), Dermatology (437 citations), Molecular Biology (3.0k citations), Biomaterials (580 citations) and Pharmaceutical Science (250 citations). Gu He has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Bo Han, Cheng Peng, Wei Huang, Xian Jiang, Xiang Wen, Lian Wang, Dan Hao, Liang Ouyang, Fengbo Wu and Xiang‐Hong He. Their work appears in journals such as European Journal of Medicinal Chemistry, Journal of Medicinal Chemistry, International Journal of Molecular Sciences, Organic Letters and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.